Letter to the editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma

Hepatology. 2023 Jan 1;77(1):E5-E6. doi: 10.1002/hep.32672. Epub 2022 Sep 3.

Authors

Zhi-Cheng Jin¹, Jian-Jian Chen, Biao Luo, Wei-Hua Zhang, Gao-Jun Teng

Affiliation

¹ Center of Interventional Radiology & Vascular Surgery, Department of Radiology , Zhongda Hospital, Medical School, Southeast University , Nanjing , China.

PMID: 35839297
DOI: 10.1002/hep.32672

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Hepatitis B virus / physiology
Hepatitis B* / drug therapy
Hepatitis B, Chronic* / drug therapy
Humans
Immune Checkpoint Inhibitors / adverse effects
Liver Neoplasms*
Virus Activation

Substances

Immune Checkpoint Inhibitors